Category Archives: The Charlton Centre

As the focus on maintaining a low COVID-19 infection rate in our communities remains a priority, Ontario has made third doses of the COVID-19 vaccines available to additional vulnerable populations.  For those listed below, third doses are offered at least … Continue reading →

After receiving some questions about the COVID-19 vaccines and the rare side effects of myocarditis and pericarditis, we decided to provide an informed update regarding these concerns. As of September 24, 2021, with 56 million COVID-19 vaccine doses given, there … Continue reading →

With flu shot season just around the corner, the National Advisory Committee on Immunization’s (NACI), updated recommendations regarding the coadministration of COVID-19 vaccines with other vaccines have arrived in a timely manner. Previously, NACI had recommended that the COVID-19 vaccines … Continue reading →

We have had many calls about the expanded list of vulnerable populations who are now eligible for a third dose of COVID-19 vaccine.  Below is an excerpt of the new guidance which includes a  list of patients who are now … Continue reading →

We have had several questions from our patients with autoimmune diseases regarding antibody testing.  The first thing to be aware of is that there are two different antibody tests.  The initial testing that labs offered is called the Total Nucleocapsid … Continue reading →

On August 17th,  Ontario updated its vaccine eligibility criteria.  Anyone turning 12 years old in 2021 can now be vaccinated, rather than having to wait until their 12th birthday.  In addition, those who are living in long-term care settings are … Continue reading →

We have all felt a burden of stress during this pandemic.  For many, it has been a time to reflect on what we really value in life and the people and experiences that we have missed.  Reflecting on one’s health … Continue reading →

World Hepatitis Day (WHD) takes place every year on July 28th, bringing the world together under a single theme to raise awareness of the global burden of viral hepatitis and to influence real change. In 2021 the theme is ‘Hepatitis … Continue reading →

Infliximab was launched by Janssen over 20 years ago under the name Remicade.  It continues to be a biologic therapy given by infusion (IV) for many autoimmune conditions including rheumatoid arthritis, ankylosing spondylitis, psoriasis, Crohn’s, and ulcerative colitis.  In the … Continue reading →

We are all aware of the importance of completing both doses of Covid-19 vaccines to get the best protection.  In light of new variants, the push is on to get second doses as soon as possible.  A recent independent study … Continue reading →